3173 results for «335»
3173 results
EuroPCR 2017 Nurses and Allied Professionals Programme Closing Ceremony
19 May 2017 – From EuroPCR 2017
Consult the session on the Closing Ceremony of the EuroPCR 2017 Nurses and Allied Professionals Programme, presented by S. Coelho, H. Eltchaninoff and D. Sparv. The State-of-the-art lecture on structural heart disease by Prof. A. Cribier sheds light on LAA occlusion.
EuroPCR 2017 Closing Ceremony
19 May 2017 – From EuroPCR 2017
Opening ceremony
08 Apr 2017 – From PCR Tokyo Valves 2017
Closing Ceremony and Awards
09 Apr 2017 – From PCR Tokyo Valves 2017
PCR London Valves 2017 Opening Ceremony - Welcome address
25 Sep 2017 – From PCR London Valves 2017
Welcome to Imaging Day
24 Sep 2017 – From PCR London Valves 2017
Welcome and introduction to PCR Innovators Day London
24 Sep 2017 – From PCR Innovators Day 2017
Legal notice
19 Oct 2018
Updated - August 22nd, 2023
AsiaPCR 2018: General Terms and conditions of sale
MASTER-DAPT: “the MASTER of high-bleeding risk trials”
28 Aug 2021
Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.
Author
Europa Group's General Terms and Conditions of Sale
12 Apr 2024
Ref 02P - Updated June 2024
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
